Weiqi Fu

北京航空航天大学

H指数:41

被引数:4,651

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tactile rolling fingertip-informed DLO shape modeling and manipulation method for bimanual cable routing

双臂电缆布线中基于触觉滚动指尖信息的DLO形状建模与操作方法

Robotics and Computer-Integrated Manufacturing

IF11.4

2026-07-090

PRE

Handedness-aware motion mapping for human-robot teleoperation via meta-motion alignment and trajectory reconstruction

基于元运动对齐和轨迹重建的手性感知运动映射用于人机遥操作

Journal of Manufacturing Systems

IF14.2

2026-05-010

PRE

Phase-Change-Activated Slippery Organogel Composite for All-in-One Anti-Corrosion, Antifouling, and Self-Cleaning

相变激活滑石有机凝胶复合材料用于一体化防腐蚀、抗污和自清洁

Energy & Environmental Materials

IF14.1

2026-04-220

OAAI

Enhanced acetate tolerance and resource recovery via adaptive evolution of Chlorella vulgaris for sustainable upcycling of organic wastewater

通过普通小球藻（Chlorella vulgaris）的适应性进化提高乙酸耐受性和资源回收，以实现有机废水的可持续升级利用。

Bioresource Technology

IF9

2026-02-160

PRE

Multi-omics dissect the molecular mechanisms driving high-lipid production in a laboratory-evolved Chlamydomonas mutant

多组学解析实验室进化型Chlamydomonas突变体中驱动高脂质生产的分子机制

Algal Research

IF1.6

2025-12-150

OAAI

Novel magnetic resonance imaging (MRI)-based radiomics for predicting perineural invasion in rectal cancer: a two-centre study

基于磁共振成像（MRI）的新型放射组学在预测直肠癌神经周围浸润中的应用：一项双中心研究

CLINICAL RADIOLOGY

IF1.9

2025-12-011

PRE

Draft genome of pin nematode Paratylenchus projectus recovered from rhizosphere of blueberry

PARASITES & VECTORS

IF3.5

2025-02-260

OAAI

miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway (vol 10, 64, 2018)

CLINICAL EPIGENETICS

IF4.4

2024-12-270

OAAI

An undiscovered circadian clock to regulate phytoplankton photosynthesis

一个未被发现的生物钟来调节浮游植物的光合作用

PNAS NEXUS

IF3.8

2024-11-060

OAAI

Adaptive Evolution Signatures in Prochlorococcus: Open Reading Frame (ORF)eome Resources and Insights from Comparative Genomics

原绿球菌的适应性进化特征: 开放阅读框 (ORF)eome资源和比较基因组学的见解

MICROORGANISMS

IF4.2

2024-08-200

OAAI

Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis (vol 183, 106376, 2022)

PHARMACOLOGICAL RESEARCH

IF10.5

2024-07-010

OAAI

ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway (vol 43, pg 2709, 2022)

ACTA PHARMACOLOGICA SINICA

IF8.4

2024-06-250

Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis (vol 43, pg 2977, 2022)

ACTA PHARMACOLOGICA SINICA

IF8.4

2024-05-131

Biomimetic Synthesis of Nanosilica by Deep Learning-Designed Peptides and Its Anti-UV Application

ADVANCED INTELLIGENT SYSTEMS

IF6.1

2024-04-100

Damage volumetric assessment and digital twin synchronization based on LiDAR point clouds

AUTOMATION IN CONSTRUCTION

IF11.5

2024-01-016

OAAI

Personalized tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in resected non-small cell lung cancer (NSCLC) with common driver genes

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

Physiological and molecular insights into adaptive evolution of the marine model diatom Phaeodactylum tricornutum under low-pH stress

JOURNAL OF CLEANER PRODUCTION

IF10

2023-08-016

PRE

Closing the Gap between Bio-Based and Petroleum-Based Plastic through Bioengineering

MICROORGANISMS

IF4.2

2022-11-2318

OAAI

CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial-mesenchymal transition, G2/M phase transition, and PANoptosis

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2022-10-0251

OAAI

Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis

PHARMACOLOGICAL RESEARCH

IF10.5

2022-09-0140

PRE

Weiqi Fu

个人简介

教育背景

工作经历

荣誉奖项

研究方向